{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:23:15Z","timestamp":1791156195836,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.autrev.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:36:18Z","timestamp":1551720978000},"page":"484-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Free light chains and autoimmunity"],"prefix":"10.1016","volume":"18","author":[{"given":"Cecilia","family":"Napodano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krizia","family":"Pocino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Stefanile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariapaola","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Ludovico","family":"Rapaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.03.003_bb0005","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.autrev.2019.03.003_bb0010","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1515\/cclm-2017-1077","article-title":"Standardization of autoimmune testing\u2014is it feasible?","volume":"56","author":"Monogioudi","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat Immunol."},{"key":"10.1016\/j.autrev.2019.03.003_bb0020","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2019.03.003_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","article-title":"Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity","volume":"82","author":"Watad","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2019.03.003_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2013.09.004","article-title":"The cryptic interplay between systemic lupus erythematosus and infections","volume":"13","author":"Rigante","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.13560","article-title":"Pathophysiological mechanisms of autoimmunity","volume":"1413","author":"Sudres","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2019.03.003_bb0040","series-title":"Immunobiology: The immune system in health and disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.autrev.2019.03.003_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM197601012940105","article-title":"Bence-Jones proteins and light chains of immunoglobulins (first of two parts)","volume":"294","author":"Solomon","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.abb.2004.08.022","article-title":"Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin kappa light chain","volume":"431","author":"Boivin","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.autrev.2019.03.003_bb0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1373\/clinchem.2005.048017","article-title":"Serum free light chain measurements move to center stage","volume":"51","author":"Bradwell","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2019.03.003_bb0060","first-page":"4","article-title":"Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?","volume":"5","author":"Brebner","year":"2013","journal-title":"Medicine Reports"},{"key":"10.1016\/j.autrev.2019.03.003_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0076-6879(85)16008-8","article-title":"Light chains of human immunoglobulins","volume":"116","author":"Solomon","year":"1985","journal-title":"Meth Enzymol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0070","first-page":"2162","article-title":"The renal handling of low molecular weight proteins","volume":"51","author":"Waldmann","year":"1972","journal-title":"II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephritic syndrome, or uremia. J Clin Invest"},{"key":"10.1016\/j.autrev.2019.03.003_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0140-6736(02)86528-X","article-title":"Papers on chemical pathology: prefaced by the Gulstonian Lectures, read at the Royal College of Physicians, 1846","volume":"50","author":"Bence Jones","year":"1847","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.03.003_bb0080","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1373\/clinchem.2011.169433","article-title":"Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation","volume":"57","author":"Hutchison","year":"2011","journal-title":"Clin Chem"},{"issue":"Pt 3","key":"10.1016\/j.autrev.2019.03.003_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0004563214553808","article-title":"Polyclonal versus monoclonal immunoglobulin-free light chains quantification","volume":"52","author":"Di Noto","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.autrev.2019.03.003_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/CCLM.2010.012","article-title":"Analytical performance of the serum free light chain assay","volume":"48","author":"Briand","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2017.09.005","article-title":"Free light chains: eclectic multipurpose biomarker","volume":"451","author":"Basile","year":"2017","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2019.03.003_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2019.03.003_bb0105","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ki.2011.94","article-title":"The biology of immunoglobulin free light chains and kidney injury","volume":"79","author":"Basnayake","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2019.03.003_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CBF.S57681","article-title":"Polyclonal free light chains: promising new biomarkers in inflammatory disease","volume":"4","author":"Hampson","year":"2014","journal-title":"Current Biomarker Findings"},{"issue":"5046","key":"10.1016\/j.autrev.2019.03.003_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/211243a0","article-title":"Synthesis of excess light chains of gamma globulin by rabbit lymph node cells","volume":"211","author":"Shapiro","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2019.03.003_bb0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cca.2011.03.007","article-title":"Free immunoglobulin light chain: its biology and implications in diseases","volume":"412","author":"Nakano","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.autrev.2019.03.003_bb0135","article-title":"Immunoglobulin formation in B lymphoid cells","volume":"6","author":"Askonas","year":"1975","journal-title":"J Clin Pathol Suppl (Assoc Clin Pathol)"},{"key":"10.1016\/j.autrev.2019.03.003_bb0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.0901129","article-title":"Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases","volume":"185","author":"Rijnierse","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0145","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.0406808102","article-title":"Elicitation of allergic asthma by immunoglobulin free light chains","volume":"102","author":"Kraneveld","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2019.03.003_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2005.12.065","article-title":"Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases","volume":"533","author":"Van der Heijden","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nm722","article-title":"Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses","volume":"8","author":"Redegeld","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tips.2008.01.004","article-title":"Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases","volume":"29","author":"Thio","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2019.03.003_bb0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/1744666X.2017.1280396","article-title":"A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner","volume":"13","author":"Rigante","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0170","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.067","article-title":"The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children","volume":"10","author":"Rigante","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ijlh.12159","article-title":"The relationship between high-sensitivity CRP and polyclonal free light chains as markers of inflammation in chronic disease","volume":"36","author":"Burmeister","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0889-857X(21)00891-7","article-title":"Systemic lupus erythematosus","volume":"16","author":"Hochberg","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2019.03.003_bb0185","article-title":"Elevated concentrations of serum immunoglobulin free light chains in systemic lupus erythematosus patients in relation to disease activity, inflammatory status, b cell activity and Epstein-Barr virus antibodies","volume":"11","author":"Draborg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2019.03.003_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.autrev.2017.11.004","article-title":"Vitamin D and systemic lupus erythematosus\u2014the hype and the hope","volume":"17","author":"Shoenfeld","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0195","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.autrev.2018.04.005","article-title":"The role of stress in the mosaic of autoimmunity: an overlooked association","volume":"17","author":"Sharif","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0205","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/08916930701510962","article-title":"Genetics of clinical expression in SLE","volume":"40","author":"Namjou","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2019.03.003_bb0210","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/rheumatology\/ket108","article-title":"Urinary free light chain is a potential biomarker for ISN\/RPS class III\/IV lupus nephritis","volume":"52","author":"Hanaoka","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2019.03.003_bb0215","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.20446","article-title":"Serum free light chains as biomarkers for systemic lupus erythematosus disease activity","volume":"63","author":"Aggarwal","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2019.03.003_bb0220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00918666","article-title":"Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin","volume":"9","author":"Hopper","year":"1989","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.1780090508","article-title":"Increase of L-chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritis","volume":"9","author":"Epstein","year":"1966","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.003_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1006686514743","article-title":"Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig","volume":"20","author":"Hopper","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0235","doi-asserted-by":"crossref","first-page":"c258","DOI":"10.1159\/000167874","article-title":"Are urinary levels of free light chains of immunoglobulins useful markers for differentiating between systemic lupus erythematosus and infection?","volume":"110","author":"Mastroianni-Kirsztajn","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.autrev.2019.03.003_bb0240","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.27.6.537","article-title":"Free immunoglobulin light chains in connective tissue diseases","volume":"27","author":"Cooper","year":"1968","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0245","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10067-010-1674-1","article-title":"Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity","volume":"30","author":"Chiche","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0250","first-page":"715","article-title":"Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement","volume":"13","author":"Hirohata","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0255","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.51.2.168","article-title":"Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis","volume":"51","author":"Tsai","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9646209","article-title":"Serological immunoglobulin-free light chain profile in myasthenia gravis patients","volume":"2018","author":"Basile","year":"2018","journal-title":"J Immunol Res"},{"issue":"10103","key":"10.1016\/j.autrev.2019.03.003_bb0265","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.03.003_bb0270","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.003_bb0275","first-page":"202","article-title":"(systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1346-8138.2009.00763.x","article-title":"B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis","volume":"37","author":"Hasegawa","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0285","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.autrev.2011.04.013","article-title":"B cells in systemic sclerosis: a possible target for therapy","volume":"10","author":"Bosello","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0290","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3899\/jrheum.140543","article-title":"Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis","volume":"42","author":"Deng","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.2006.052159","article-title":"Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome","volume":"66","author":"Gottenberg","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0305","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.kjms.2013.01.013","article-title":"Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels","volume":"29","author":"Ye","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.autrev.2019.03.003_bb0310","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s10067-016-3437-0","article-title":"The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease","volume":"35","author":"Bramlage","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0315","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3899\/jrheum.130905","article-title":"Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis","volume":"41","author":"Scarsi","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0320","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1136\/ard.2009.126441","article-title":"Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity","volume":"69","author":"Kormelink","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0325","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","article-title":"Primary Sjogren\u2019s syndrome: clinical and immunologic disease patterns in a cohort of 400 patients","volume":"81","author":"Garcia-Carrasco","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2019.03.003_bb0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1756-185X.2012.01717.x","article-title":"A study of the prevalence of sicca symptoms and secondary Sjogren\u2019s syndrome in patients with rheumatoid arthritis, and its association to disease activity and treatment profile","volume":"15","author":"Haga","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0335","first-page":"256","article-title":"Primary Sjogren\u2019s syndrome: clinical and serological feature of a single centre","volume":"57","author":"Baldini","year":"2005","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2019.03.003_bb0340","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sjogren\u2019s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0345","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/kep149","article-title":"Cytokine and autoantibody profiling related to histopathological features in primary Sjogren\u2019s syndrome","volume":"48","author":"Reksten","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2019.03.003_bb0350","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren\u2019s syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0355","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1756-185X.12965","article-title":"Diagnostic accuracy of salivary and serum-free light chain assays in primary Sj\u00f6gren's syndrome: a pilot study","volume":"20","author":"Sandhya","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0360","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0002-9343(80)90215-6","article-title":"Non-IgM monoclonal gammopathy in patients with Sj\u00f6gren's syndrome","volume":"68","author":"Sugai","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2019.03.003_bb0365","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary Sjogren\u2019s syndrome: a systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.03.003_bb0370","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/rheumatology\/key180","article-title":"Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sj\u00f6gren\u2019s syndrome","volume":"57","author":"Verstappen","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2019.03.003_bb0375","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1136\/annrheumdis-2015-208504","article-title":"EULAR Sj\u00f6gren Task Force. development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0380","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren's Task Force. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2019.03.003_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sj\u00f6gren\u2019s Syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0390","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0897.2006.00434.x","article-title":"Autoantibodies and prediction of reproductive failure","volume":"56","author":"Shoenfeld","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2019.03.003_bb0395","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.autrev.2008.08.001","article-title":"Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies","volume":"7","author":"Meroni","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.03.003_bb0400","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1191\/0961203306lu2274rr","article-title":"Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity","volume":"15","author":"Shepshelovich","year":"2006","journal-title":"Lupus"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:28Z","timestamp":1761599668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1568997219300564"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.03.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free light chains and autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}